Literature DB >> 9185766

Hepatic cholesterol metabolism in human obesity.

D Ståhlberg1, M Rudling, B Angelin, I Björkhem, P Forsell, K Nilsell, K Einarsson.   

Abstract

Hepatic cholesterol metabolism was studied in operative liver biopsies from 17 morbidly obese subjects and compared with that in samples from 15 nonobese controls. The aim was to understand the mechanisms causing the hypersecretion of cholesterol into bile. The content of cholesteryl esters was increased threefold in the liver of obese subjects compared with that of the controls (P < .0001). The activity and the messenger RNA (mRNA) level of 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate limiting enzyme for cholesterol synthesis, were higher in the obese subjects compared with the nonobese subjects (75% and 140%, respectively; P < .01). In the obese subjects, the activity and mRNA level of cholesterol 7alpha-hydroxylase, which regulates the catabolism of cholesterol to bile acids, were also increased by 140% (P < .05) and 180% (P = .06), respectively, as compared with the controls. There was a significant correlation between the activities and the mRNA levels of cholesterol 7alpha-hydroxylase among the obese subjects (r = +0.65, P < .01). The activities of acyl-coenzyme A:cholesterol acyltransferase (ACAT), which governs cholesteryl ester formation, in obese and nonobese patients were 12.5 +/- 1.7 and 8.1 +/- 1.2 pmol/min/mg protein, respectively (P < .05), and the low-density lipoprotein (LDL) receptor mRNA levels were 5.3 +/- 0.7 and 4.5 +/- 0.9 molecules of mRNA/microg of RNA, respectively. We conclude that the activities of three key enzymes in hepatic cholesterol metabolism were increased in morbidly obese subjects compared with nonobese controls, as were mRNA levels of HMG CoA reductase and cholesterol 7alpha-hydroxylase. The mRNA level of the LDL receptor in the obese subjects was not significantly changed. The hypersecretion of cholesterol occurring in obesity is neither due to a reduced conversion of cholesterol to bile acids nor to a decreased esterification of hepatic cholesterol but may be due to an increased synthesis of cholesterol.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9185766     DOI: 10.1002/hep.510250623

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  27 in total

1.  Intracerebroventricular leptin regulates hepatic cholesterol metabolism.

Authors:  Sonya Vanpatten; George B Karkanias; Luciano Rossetti; David E Cohen
Journal:  Biochem J       Date:  2004-04-15       Impact factor: 3.857

2.  Puerariae flos alleviates metabolic diseases in Western diet-loaded, spontaneously obese type 2 diabetic model mice.

Authors:  Koshi Kubo; Tsutomu Shimada; Rei Onishi; Masahito Tsubata; Tomoyasu Kamiya; Rika Nagamine; Seiichi Iizuka; Yoshimichi Sai; Sakae Amagaya; Masaki Aburada; Ken-ichi Miyamoto
Journal:  J Nat Med       Date:  2012-02-16       Impact factor: 2.343

3.  Pediatric obesity and gallstone disease.

Authors:  Corinna Koebnick; Ning Smith; Mary Helen Black; Amy H Porter; Bradley A Richie; Sharon Hudson; Deborah Gililland; Steven J Jacobsen; George F Longstreth
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-09       Impact factor: 2.839

Review 4.  Bile acids in glucose metabolism and insulin signalling - mechanisms and research needs.

Authors:  Tiara R Ahmad; Rebecca A Haeusler
Journal:  Nat Rev Endocrinol       Date:  2019-10-15       Impact factor: 43.330

5.  Maternal hypercholesterolemia programs dyslipidemia in adult male mouse progeny.

Authors:  Joyce Mathew; Sze-Chi Huang; Jerad H Dumolt; Mulchand S Patel; Todd C Rideout
Journal:  Reproduction       Date:  2020-07       Impact factor: 3.906

6.  Serum leptin levels and insulin resistance are associated with gallstone disease in overweight subjects.

Authors:  Nahum Méndez-Sánchez; Luisa-B Bermejo-Martínez; Yolanda Viñals; Norberto-C Chavez-Tapia; Irina Vander Graff; Guadalupe Ponciano-Rodríguez; Martha-H Ramos; Misael Uribe
Journal:  World J Gastroenterol       Date:  2005-10-21       Impact factor: 5.742

7.  Atorvastatin increases intestinal expression of NPC1L1 in hyperlipidemic men.

Authors:  André J Tremblay; Benoît Lamarche; Valéry Lemelin; Lizbeth Hoos; Suzanne Benjannet; Nabil G Seidah; Harry R Davis; Patrick Couture
Journal:  J Lipid Res       Date:  2010-12-01       Impact factor: 5.922

8.  Increased Bile Acid Synthesis and Impaired Bile Acid Transport in Human Obesity.

Authors:  Rebecca A Haeusler; Stefania Camastra; Monica Nannipieri; Brenno Astiarraga; Jose Castro-Perez; Dan Xie; Liangsu Wang; Manu Chakravarthy; Ele Ferrannini
Journal:  J Clin Endocrinol Metab       Date:  2015-12-18       Impact factor: 5.958

Review 9.  Cholesterol-metabolizing cytochromes P450: implications for cholesterol lowering.

Authors:  Irina A Pikuleva
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-11       Impact factor: 4.481

10.  Biliary lipids and cholesterol crystal formation in leptin-deficient obese mice.

Authors:  Deborah A Swartz-Basile; Matthew I Goldblatt; Seong Ho Choi; Carol Svatek; Khoi Tran; Attila Nakeeb; Henry A Pitt
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.